<unk>  is a cystic fibrosis transmembrane conductance regulator that is FDA approved for the treatment of cystic fibrosis.   Common adverse reactions include headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, and dizziness.
Ivacaftor
Tiotropium
Diflorasone
Formoterol
Zafirlukast
Xamoterol
Arformoterol tartrate
Fluticasone